UnitedHealthcare gives Remicade biosims a leg up with changes to Medicare plansAllbiopro2018-10-16T09:52:14+09:0010월 16th, 2018|
Can Kadcyla give Roche a softer landing when Herceptin biosims hit? New data could helpAllbiopro2018-10-16T09:51:47+09:0010월 16th, 2018|
Pharma TV buys so far top last year’s $1B spend; AbbVie, Pfizer lead SeptemberAllbiopro2018-10-16T09:51:21+09:0010월 16th, 2018|
Got tech ideas for diabetes? Novo wants you for its crowdsourcing challengeAllbiopro2018-10-16T09:50:54+09:0010월 16th, 2018|
Neopharma snatches Dr. Reddy’s API business as it continues global expansionAllbiopro2018-10-16T09:50:26+09:0010월 16th, 2018|
Alnylam drops early filing plan for porphyria drug givosiranAllbiopro2018-10-16T09:49:54+09:0010월 16th, 2018|
F-star names ex-Immunocore CEO Eliot Forster as leaderAllbiopro2018-10-16T09:49:02+09:0010월 16th, 2018|
New York biotech snaps up Eli Lilly neuro veteran as CSOAllbiopro2018-10-16T09:48:35+09:0010월 16th, 2018|
Merck drops Lantus biosimilar, blames pricing and production cost concernsAllbiopro2018-10-16T09:48:09+09:0010월 16th, 2018|
BMS invests in Compugen, grants access to Opdivo for combo trialAllbiopro2018-10-16T09:47:41+09:0010월 16th, 2018|
Microfluidic molecular exchanger helps control therapeutic cell manufacturingAllbiopro2018-10-16T09:45:29+09:0010월 16th, 2018|
MilliporeSigma Offers Insect Platform for Viral Vaccines and Gene Therapy DevelopmentAllbiopro2018-10-16T09:44:10+09:0010월 16th, 2018|
October 12 Research Roundup: Alzheimer’s, CRISPR, Breast Cancer and Global WarmingAllbiopro2018-10-13T13:48:39+09:0010월 13th, 2018|
Global Biopharma Companies Top Forbes’ List of World’s Best EmployersAllbiopro2018-10-13T13:48:13+09:0010월 13th, 2018|
BMS’ Opdivo Flounders in Phase III Trial for Small Cell Lung CancerAllbiopro2018-10-13T13:47:47+09:0010월 13th, 2018|
A Look Inside New MS Data With Biogen’s Medical Director of Clinical DevelopmentAllbiopro2018-10-13T13:47:21+09:0010월 13th, 2018|